About Us
About Us
About CARE BEST CARE
A biopharmaceutical company based in Dongyang, central-eastern Zhejiang, dedicated to vascular health and neural repair.
A biopharmaceutical company based in Dongyang, Zhejiang, dedicated to vascular health and neural repair.
Company Overview
Company Overview
Company Overview
Kebeijia (Zhejiang) Pharmaceutical Technology Co., Ltd. is located in Dongyang, a historic economic hub in central Zhejiang. With proprietary intellectual property and core technologies, we specialize in the research, development, production, and sales of innovative natural plant-based drugs and functional health products.
Our mission is to conquer major human diseases. Leveraging modern medical research, traditional medicine theory and practice, we uncover bioactive compounds from natural plants to build a "vascular youth" health management product system—safeguarding vascular health through evidence-based science.
Our Strengths
Four Core Advantages
Four Core Strengths
An integrated model of medical research and development, building end-to-end capabilities from research to product.
01
Integrated Medical Research
Establish a self-built medical research center and regenerative medicine experimental center, advancing scientific research and product commercialization in tandem.
02
Global Presence
Collaborative R&D and market operations across Hong Kong, Japan, Macao, and North America
03
self-owned intellectual property
12 international PCT patents covering China, the U.S., EU, Japan, Australia, and more.
04
Expert Team
Co-developed in-depth by professor/PhD teams from three leading universities, integrating industry, academia, research, and healthcare.
Brand Story
Brand Story, Mission & Vision
Our Story, Mission, and Vision
「CARE BEST CARE Premium Care"Science-backed Care" is the core philosophy of Kebeija. We believe that the cornerstone of vascular health management lies in evidence-based science—leveraging modern medical research to validate traditional medicinal wisdom, ensuring the active ingredients of natural plants meet contemporary health needs.
From systematic research on extracts from Luanbuzheng to "Angioenhancin," Kebeijia has forged a unique path.From symptomatic support to disease-modifying therapydifferentiated research pathways to explore scientific strategies for promoting angiogenesis and restoring neurological function.
Mission
Protect vascular health with evidence-based science, ensuring every heartbeat and blood flow remains optimal.
Vision
To become a globally influential biopharmaceutical company in the fields of vascular health and neural repair.
Values
Integrated Medical Research · Global Collaboration · Independent IP · Expert Co-Creation
Global Footprint
Global Industry Layout
Global Industrial Footprint
Centered on China headquarters, R&D and market entities across multiple locations collaborate in sync.
Kebeijia (Zhejiang) Pharmaceutical Technology Co., Ltd.
China HQ · R&D and Operations Center
Kobei (Hong Kong) Medical Research Center
Source of R&D
Kobeika (Japan) Pharmaceutical Co., Ltd.
Pharmaceutical Collaboration
Biosan (Macau) Pharmaceutical Co., Ltd.
Production Collaboration
Cobega (North America) Pharmaceutical Co., Ltd.
Market & Registration
Milestones
History
Development Milestones
Foundation Phase
Establish a direction for innovative natural plant-based drugs
Based in Dongyang, Zhejiang, we operate our own Medical Research Center and Regenerative Medicine Experimental Center, focusing on vascular health and nerve repair.
Layout Phase
Build a matrix of proprietary intellectual property
Have successively secured 12 international PCT patents covering China, the United States, the European Union, Canada, Japan, Australia, and Singapore.
Verification period
Advance efficacy and safety research
Completed pre-experiments on substance basis and pharmacodynamics in collaboration with Zhejiang University and other institutions; In 2023 year 6 month, the investigational preclinical trial was launched at Sir Run-Run Shaw Hospital of Zhejiang University.
Listing Period
Introducing the Shengzhi Su Product Line
The Shengzhi Su Capsule and Plant-Based Oral Antimicrobial Paste have been launched sequentially, establishing a "Vascular Youth" health management product ecosystem.
Curious about our products and research capabilities?
Learn More About Our Products and Research
Contact KBJ for product information and partnership proposals.